Skip to main content
Figure 2 | World Journal of Surgical Oncology

Figure 2

From: Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review

Figure 2

Histopathology of the tumor of the patient. A mount of large and bizarre giant cells compatible with a diagnosis of glioblastoma in the H-E staining (A). Immunohistochemically, the MGMT promoter was weakly methylated (B) and strong mutation of PTEN genes (C), P53 (D), and amplificated VEGF genes (E) were seen. The immunofluorescent staining of 1p19q showed no deficiency existed (F).

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us